8-02-2023, 13:03

WISeKey’s Semiconductors, NFTs, Post Quantum and Blockchain

WISeKey’s Semiconductors, NFTs, Post Quantum and Blockchain Solutions Secure Smart Cities Carlos Moreira, WISeKey’s
Globe Newswire8-02-2023, 13:03
7-02-2023, 13:33

Continued strong Cresemba® (isavuconazole) sales

Basel/Allschwil, Switzerland, February 07, 2023 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage
Globe Newswire7-02-2023, 13:33
6-02-2023, 13:20

Sandoz Biologics License Application for proposed

Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of
Globe Newswire6-02-2023, 13:20
4-02-2023, 06:41

Patients with hidradenitis suppurativa experienced

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment
Globe Newswire4-02-2023, 06:41
1-02-2023, 13:17

European Commission approves label expansion of Roche’s

Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient
Globe Newswire1-02-2023, 13:17
31-01-2023, 23:53

Invitation to Idorsia's full year financial results 2022

Idorsia will publish its full year financial results 2022 on Tuesday February 7, 2023, at 07:00 CET An investor
Globe Newswire31-01-2023, 23:53
31-01-2023, 13:22

Idorsia submits European marketing authorisation

The application includes data from the Phase 3 registration study of patients with resistant hypertension, where
Globe Newswire31-01-2023, 13:22
30-01-2023, 22:54

WISeKey Launches eTreeNFT.com Connecting Trees, NFTs and

WISeKey Launches eTreeNFT.com Connecting Trees, NFTs and Crypto on a Unique Opportunity for Creating New and Totally
Globe Newswire30-01-2023, 22:54
30-01-2023, 13:17

Sandoz receives positive CHMP opinion for citrate-free high

Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications of reference
Globe Newswire30-01-2023, 13:17